For the second straight year AMHCA has received an education grant from AstraZeneca Pharmaceuticals.
AstraZeneca is one of the world's leading investors in pharmaceutical research and development. AstraZeneca (nearly 100 years old) is proud of its medications addressing mental illness.
AMHCA celebrates AstraZeneca's many community outreach efforts and its interest in supporting mental health awareness around the globe.